Another notable example of the adverse effects of current ADCs is the occurrence of T-DXd-induced ILD in both HER2-expressing metastatic colorectal cancer [11] and non-small-cell lung cancer (NSCLC) [6]. This evidence concerns the gene ERBB2 and metastatic colorectal cancer.